Log in to save to my catalogue

Biocompatibility and Effectiveness Evaluation of a New Hemostatic Embolization Agent: Thrombin Loade...

Biocompatibility and Effectiveness Evaluation of a New Hemostatic Embolization Agent: Thrombin Loade...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5337789

Biocompatibility and Effectiveness Evaluation of a New Hemostatic Embolization Agent: Thrombin Loaded Alginate Calcium Microsphere

About this item

Full title

Biocompatibility and Effectiveness Evaluation of a New Hemostatic Embolization Agent: Thrombin Loaded Alginate Calcium Microsphere

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

BioMed research international, 2017-01, Vol.2017 (2017), p.1-10

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Background. Until now, there has been no ideal embolization agent for hemorrhage in interventional treatment. In this study, the thrombin was encapsulated in alginate calcium microsphere using electrostatic droplet technique to produce new embolization agent: thrombin loaded alginate calcium microspheres (TACMs). Objectives. The present work was to...

Alternative Titles

Full title

Biocompatibility and Effectiveness Evaluation of a New Hemostatic Embolization Agent: Thrombin Loaded Alginate Calcium Microsphere

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5337789

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5337789

Other Identifiers

ISSN

2314-6133

E-ISSN

2314-6141

DOI

10.1155/2017/1875258

How to access this item